OpGen’s Subsidiary Curetis Meets Milestones in Collaborative Research Project with InfectoGnostics
03 avr. 2023 07h30 HE
|
OpGen, Inc.
PREPLEX project is part of broader InfectoGnostics Research Campus in Jena, GermanyTotal project volume of PREPLEX collaborative research is approximately $ 0.9 Mio ROCKVILLE, Md., April 03, 2023 ...
North America Antimicrobial Resistance Diagnostics Market Research Report 2022-2028: Industry Developments, Competitive Landscape, Partnerships and Collaborations, & Product Launches and Expansions
10 mars 2023 07h08 HE
|
Research and Markets
Dublin, March 10, 2023 (GLOBE NEWSWIRE) -- The "North America Antimicrobial Resistance Diagnostics Market Size, Share & Industry Trends Analysis Report By Technology, By End User (Hospitals,...
Global Active Pharmaceutical Ingredient Market Report to 2027: Emerging Biosimilars Market and Highly Potent Active Pharmaceutical Ingredients Present Opportunities
28 févr. 2023 12h48 HE
|
Research and Markets
Dublin, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product...
Healthcare Industry Veteran Jamie Condie Joins Selux Diagnostics' Board of Directors
14 févr. 2023 07h30 HE
|
Selux Diagnostics
BOSTON, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Selux Diagnostics, a biotech startup in Boston whose mission is to combat superbug infections and antimicrobial resistance (AMR), announced today that...
Global Antimicrobial Resistance Diagnostic Market Analysis Report 2023: Strategies and Trends by Pathogen and Technology with Executive Guides and 5 Year Forecasts
26 janv. 2023 06h28 HE
|
Research and Markets
Dublin, Jan. 26, 2023 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, with Executive Guides and Customization" report has been...
Global Antibiotic Resistance Market Research Report 2023: The Changing Road to New Antibiotics & Technologies with 5 Year Forecasts
13 janv. 2023 05h03 HE
|
Research and Markets
Dublin, Jan. 13, 2023 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &...
Global Antimicrobial Resistance Diagnostics Market Report 2023: Increasing Incidences of Hospital-Acquired Infections Drives Demand
05 janv. 2023 04h23 HE
|
Research and Markets
Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "Global Antimicrobial Resistance Diagnostics Market Size, Share & Industry Trends Analysis Report By Technology, By End User (Hospitals, Diagnostic...
Global Active Pharmaceutical Ingredient Global Market Report 2022: Growing Importance of Generics Bolsters Sector
28 déc. 2022 06h58 HE
|
Research and Markets
Dublin, Dec. 28, 2022 (GLOBE NEWSWIRE) -- The "Global Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product...
Summit Therapeutics Presents Ri-CoDIFy Trial Results for Microbiome-Sparing Ridinilazole at IDWeek 2022
20 oct. 2022 17h15 HE
|
Summit Therapeutics Inc.
Ridinilazole resulted in a 53% relative risk reduction in recurrence of C. difficile infection compared to treatment with vancomycin Ridinilazole preserved the gut microbiome compared to...
Dr. James S. Lewis II, Antibiotic Susceptibility Test Expert, Joins as Chair of Selux Diagnostics' Clinical Advisory Board
17 oct. 2022 10h01 HE
|
Selux Diagnostics
BOSTON, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Selux Diagnostics, a biotech startup in Boston whose mission is to combat superbug infections and antimicrobial resistance (AMR), announced today that Dr....